Case Name: ELI LILLY AND COMPANY, Plaintiff-Appellant, v. ACTAVIS ELIZABETH LLC, Defendant-Appellee, and Sun Pharmaceutical Industries, Ltd., Defendant-Appellee, and Sandoz, Inc., Defendant-Appellee, and Mylan Pharmaceuticals Inc., Defendant-Appellee, and Apotex Inc., Defendant-Appellee, and Aurobindo Pharma Ltd., Defendant-Appellee, and Teva Pharmaceuticals USA, Inc., Defendant-Appellee
Court: United States Court of Appeals for the Federal Circuit
Jurisdiction: United States
Decision Date: 2010-09-09
Citations: 449 F. App'x 24
Docket Number: No. 2010-1500
Parties: ELI LILLY AND COMPANY, Plaintiff-Appellant, v. ACTAVIS ELIZABETH LLC, Defendant-Appellee, and Sun Pharmaceutical Industries, Ltd., Defendant-Appellee, and Sandoz, Inc., Defendant-Appellee, and Mylan Pharmaceuticals Inc., Defendant-Appellee, and Apotex Inc., Defendant-Appellee, and Aurobindo Pharma Ltd., Defendant-Appellee, and Teva Pharmaceuticals USA, Inc., Defendant-Appellee.
Judges: 
Reporter: West's Federal Appendix
Volume: 449
Pages: 24–24

Head Matter:
ELI LILLY AND COMPANY, Plaintiff-Appellant, v. ACTAVIS ELIZABETH LLC, Defendant-Appellee, and Sun Pharmaceutical Industries, Ltd., Defendant-Appellee, and Sandoz, Inc., Defendant-Appellee, and Mylan Pharmaceuticals Inc., Defendant-Appellee, and Apotex Inc., Defendant-Appellee, and Aurobindo Pharma Ltd., Defendant-Appellee, and Teva Pharmaceuticals USA, Inc., Defendant-Appellee.
No. 2010-1500.
United States Court of Appeals, Federal Circuit.
Sept. 9, 2010.

Opinion:
ORDER
Defendants-Appellees Aurobindo Phar-ma Ltd., Mylan Pharmaceuticals Inc., Sun Pharmaceutical Industries, Ltd., Sandoz, Inc., and Apotex Inc. have filed with the District Court cross appeals docketed as 2010-1520, -1521, -1522, -1523, and -1524 respectively, which this court deems improperly filed.
Upon consideration thereof,
IT IS ORDERED THAT:
Pursuant to this court's order of August 31, 2010, the cross appeals are DISMISSED for lack of jurisdiction.